| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.03 |